Trial NCT01470651

View at ClinicalTrials.gov 
Org. Study IDs: C10953/6285

Last trial update was posted on 2017-02-10

MeSH Interventions

Modafinil

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C

Other Conditions


Stopping Reasons

European Medicines Agency issued a drug/drug interaction: sofosbuvir/modafinil

Limitations And Caveats

It is difficult to attribute side effects to Armodafinil or placebo given patients were undergoing Hepatitis C Treatment throughout the trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID